Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2019

05.01.2019 | Preclinical study

Three-dimensional tumor visualization of invasive breast carcinomas using whole-mount serial section histopathology: implications for tumor size assessment

verfasst von: G. M. Clarke, C. M. B. Holloway, J. T. Zubovits, S. Nofech-Mozes, M. Murray, K. Liu, D. Wang, A. Kiss, M. J. Yaffe

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Linear tumor size (T-size) estimated with conventional histology informs breast cancer management. Previously we demonstrated significant differences in margin and focality estimates using conventional histology versus digital whole-mount serial sections (WMSS). Using WMSS we can measure T-size or volume. Here, we compare WMSS T-size with volume, and with T-size measured conventionally. We also compare the ellipsoid model for calculating tumor volume to direct, WMSS measurement.

Methods

Two pathologists contoured regions of invasive carcinoma and measured T-size from both WMSS and (simulated) conventional sections in 55 consecutive lumpectomy specimens. Volume was measured directly from the contours. Measurements were compared using the paired t-test or Spearman’s rank-order correlation. A five-point ‘border index’ was devised and assigned to each case to parametrize tumor shape considering ‘compactness’ or cellularity. Tumor volumes calculated assuming ellipsoid geometry were compared with direct, WMSS measurements.

Results

WMSS reported significantly larger T-size than conventional histology in the majority of cases [61.8%, 34/55; means = (2.34 cm; 1.99 cm), p < 0.001], with a 16.4% (9/55) rate of ‘upstaging’. The majority of discordances were due to undersampling. T-size and volume were strongly correlated (r = 0.838, p < 0.001). Significantly lower volume was obtained with WMSS versus ellipsoid modeling [means = (1.18 cm3; 1.45 cm3), p < 0.001].

Conclusions

Significantly larger T-size is measured with WMSS than conventionally, due primarily to undersampling in the latter. Volume and linear size are highly correlated. Diffuse tumors interspersed with normal or non-invasive elements may be sampled less extensively than more localized masses. The ellipsoid model overestimates tumor volume.
Literatur
1.
Zurück zum Zitat Fisher B, Slack NH, Bross ID (1969) Cancer of the breast: size of neoplasm and prognosis. Cancer 24:1071–1080CrossRefPubMed Fisher B, Slack NH, Bross ID (1969) Cancer of the breast: size of neoplasm and prognosis. Cancer 24:1071–1080CrossRefPubMed
2.
Zurück zum Zitat Tabar L, Vitak B, Chen HH et al (2000) The Swedish Two-County Trial twenty years later. updated mortality results and new insights from long-term follow-up. Radiol Clin N Am 38:625–651CrossRefPubMed Tabar L, Vitak B, Chen HH et al (2000) The Swedish Two-County Trial twenty years later. updated mortality results and new insights from long-term follow-up. Radiol Clin N Am 38:625–651CrossRefPubMed
3.
Zurück zum Zitat Leitner SP, Swern AS, Weinberger D et al (1995) Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0). Cancer 76:2266–2274CrossRefPubMed Leitner SP, Swern AS, Weinberger D et al (1995) Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0). Cancer 76:2266–2274CrossRefPubMed
4.
Zurück zum Zitat Koscielny S, Tubiana M, Le MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715CrossRefPubMedPubMedCentral Koscielny S, Tubiana M, Le MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Amin M, Edge S, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer, ChicagoCrossRef Amin M, Edge S, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer, ChicagoCrossRef
6.
Zurück zum Zitat Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187CrossRefPubMed Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187CrossRefPubMed
7.
Zurück zum Zitat Koscielny S, Tubiana M, Lê MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715CrossRefPubMedPubMedCentral Koscielny S, Tubiana M, Lê MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Smart CR, Myers MH, Gloeckler LA (1978) Implications from SEER data on breast cancer management. Cancer 41:787–789CrossRefPubMed Smart CR, Myers MH, Gloeckler LA (1978) Implications from SEER data on breast cancer management. Cancer 41:787–789CrossRefPubMed
9.
Zurück zum Zitat Lester S, Bose S, Chen Y-Y et al (2013) Protocol for the examination of specimens from patients with invasive carcinoma of the breast protocol applies to all invasive carcinomas of the breast, including ductal. Arch Pathol Lab Med 133(10):1515–1538 Lester S, Bose S, Chen Y-Y et al (2013) Protocol for the examination of specimens from patients with invasive carcinoma of the breast protocol applies to all invasive carcinomas of the breast, including ductal. Arch Pathol Lab Med 133(10):1515–1538
10.
Zurück zum Zitat Graham R, Homer MJ, Katz J et al (2002) The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg 184:89–93CrossRefPubMed Graham R, Homer MJ, Katz J et al (2002) The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg 184:89–93CrossRefPubMed
14.
17.
Zurück zum Zitat Guth U, Brenckle D, Huang DJ et al (2009) Three-dimensional pathological size assessment in primary breast carcinoma. Breast Cancer Res Treat 116:257–262CrossRefPubMed Guth U, Brenckle D, Huang DJ et al (2009) Three-dimensional pathological size assessment in primary breast carcinoma. Breast Cancer Res Treat 116:257–262CrossRefPubMed
18.
19.
Zurück zum Zitat Tsai CH, Lin CM, Hsieh CC et al (2006) Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer. Thorac Cardiovasc Surg 54:537–543CrossRefPubMed Tsai CH, Lin CM, Hsieh CC et al (2006) Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer. Thorac Cardiovasc Surg 54:537–543CrossRefPubMed
20.
Zurück zum Zitat Mai KT, Mokhtar G, Burns BF et al (2003) A simple technique for calculation of the volume of prostatic adenocarcinomas in radical prostatectomy specimens. Pathol Res Pr 199:599–604CrossRef Mai KT, Mokhtar G, Burns BF et al (2003) A simple technique for calculation of the volume of prostatic adenocarcinomas in radical prostatectomy specimens. Pathol Res Pr 199:599–604CrossRef
26.
Zurück zum Zitat Wapnir IL, Wartenberg DE, Greco RS (1996) Three dimensional staging of breast cancer. Breast Cancer Res Treat 41:15–19CrossRefPubMed Wapnir IL, Wartenberg DE, Greco RS (1996) Three dimensional staging of breast cancer. Breast Cancer Res Treat 41:15–19CrossRefPubMed
29.
Zurück zum Zitat Jackson PA, Merchant W, McCormick CJ, Cook MG (1994) A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch 425:243–248CrossRefPubMed Jackson PA, Merchant W, McCormick CJ, Cook MG (1994) A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch 425:243–248CrossRefPubMed
Metadaten
Titel
Three-dimensional tumor visualization of invasive breast carcinomas using whole-mount serial section histopathology: implications for tumor size assessment
verfasst von
G. M. Clarke
C. M. B. Holloway
J. T. Zubovits
S. Nofech-Mozes
M. Murray
K. Liu
D. Wang
A. Kiss
M. J. Yaffe
Publikationsdatum
05.01.2019
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-05122-7

Weitere Artikel der Ausgabe 3/2019

Breast Cancer Research and Treatment 3/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.